Rigel Pharmaceuticals logo
Rigel Pharmaceuticals RIGL
$ 27.46 0.88%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Rigel Pharmaceuticals Deferred Revenue 2011-2024 | RIGL

Annual Deferred Revenue Rigel Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.36 M 1.37 M 2.6 M 3.02 M 25.3 M 1.03 M - - 13.4 M - - 666 K 129 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
25.3 M 129 K 5.43 M

Quarterly Deferred Revenue Rigel Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
1.36 M 1.36 M 1.36 M 1.36 M 1.36 M 1.37 M 1.37 M 1.37 M - 2.1 M 2.6 M 3.16 M 5.81 M 9.5 M 3.02 M 3.02 M 3.02 M 3.02 M 25.3 M 25.3 M 25.3 M 25.3 M 1.03 M 1.03 M 1.03 M 1.03 M - - - - - - 3.76 M 8.59 M 13.4 M 13.4 M 13.4 M 13.4 M - - - - - - - - - - - - - - 105 K -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
25.3 M 105 K 6.8 M